EDITORIAL
In the early 1970s the hypothesis that certain viruses might infect cells, alter host nucleic acids and thence cell surface proteins so as to stimulate antibody responses that would lead to the disease manifestations characteristic of systemic lupus erythematosus (SLE) was under active investigation. 1 Prominent amongst the suspects was the C-type RNA retrovirus. 2 ('Type-C' referred to viruses containing reverse transcriptase of a particular electron microscopic appearance.) The identification of cytoplasmic tubuloreticular structures resembling myxovirus nucleocapsids in murine and human lupus tissues 3 had stimulated what Tom Clancy might have described as 'The Hunt for Retrovirus'.
Although reports of multiple cases in single families and an increased incidence in black women 4 and the appearance of lupus-like disorders in complement deficiency states, 5 had suggested a role for genetic factors in the pathogenesis of SLE, an important population study of that time was not supportive, 6 and, given the predominance of the viral hypothesis, the contribution of a genetic component was considered to be low.
During the winter of 1974 I was a rheumatology fellow of Dr Charles Christian at the Hospital for Special Surgery in New York City. The research project I had chosen for my fellowship was not going anywhere. In a phrase, I was unable to distinguish the trees from the forest. As I admitted to my mentor, I had read all the available literature about this particular disease and had learned everything about it except what would be feasible and useful to study. Dr Christian seemed to be of the same mind (or at least sympathetic to my plight) for he offered me an alternative. 'Sid, I have a woman in my practice who has SLE. Her identical twin sister does not. If you can figure out why one of these twins has lupus and the other does not, you will have discovered the cause of lupus and you will win the Nobel Prize.' Now, that seemed like a reasonable goal for my fellowship! And though I suspect his charge was largely tongue-in-cheek, I record this vignette for as consequential as were the findings of the twin study, of at least equal importance were some important lessons I learned about mentoring: first, engagement and excitement can be encouraged by directed focus and incentive; and second, research should proceed unprejudiced by any expected outcome. Only at the end did Dr Christian mention that he had anticipated an entirely different result from the study he had engendered.
I began with a review of the literature. The first set of twins of which at least one had SLE had been reported in 1951 by Davis and Gutridge. 7 By 1975 there had been 19 reports published of 17 sets of twins, 16 monozygotic (MZ). Of those 17 sets, 16 were concordant for SLE, as was the one dizygotic (DZ) set. 8 I learned that twins are interesting experiments of nature. By comparing MZ twins which presumably share the same genome and the same environment with DZ twins who have different genomes but share the same environment, one should be able to distinguish the influences of nature from those of nurture. Unfortunately, in the 'real world' things are not so simple: MZ twins do not share exactly the same environment, and twinning is an unusual enough event that sufficient cases to study and compare are hard to come by. Furthermore, MZ twins are noticed, studied and reported more readily and frequently than DZ twins. Thus, most of the literature of the time was considered anecdotal.
Still, some of the 'anecdotal' reports were difficult to ignore. For example, Koreleva et al. had described a set of MZ twins who had been sent to an orphanage 11 days after their birth. One, adopted at age 16 months, was raised in a large city; the other, adopted at 25 months, had been raised in a rural environment. They both developed virtually identical clinical presentations of SLE within one month of each other at 14 years of age, one case precipitated by an otitis media, the other by sun exposure 9 .
The single creative decision I made in this entire project was to not immediately begin to study the twins offered by Dr Christian, rather to search out other twin sets so that any bench work that I might perform would not be as anecdotal as had been the literature to that point. Thus began a very successful and gratifying collaboration with the coauthors of our 1975 twin paper as well as many other physician and lupus lay groups in the New York City metropolitan area.
We identified 12 sets of twins, seven of nine definitely MZ and three DZ. Of the seven definitely MZ twin sets, four were concordant for SLE; of the three DZ sets, all were discordant. We calculated that from the New York City metropolitan area that we had found our twins, that unless the unlikely circumstance of twinning itself increasing susceptibility to SLE were at play, we had identified at least half of the expected cases, and that even were all of the unidentified sets discordant, the rate of concordance still would have been at least 25%. We concluded that there was a significant genetic influence in the pathogenesis of the disease that could not be ignored. 8 Now, 30 years later, there are about 247 sets of twins in the literature. (There probably are twin sets reported more than once, first as case reports and then included later in laboratory studies that I was unable to distinguish). 8, Of the 151 MZ sets, 60 are concordant. Of the 96 DZ sets, four are concordant. My review suggests that in recent decades there has been an increased tendency to report discordant MZ sets, selected for study in an effort to identify clinical and laboratory differences that might lead to an answer to Dr Christian's original question.
Some surveys have suggested a lower concordance rate in MZ twins 46, 47 than we reported in 1975. On the other hand, I would like to emphasize that over time the concordance rate increases. 61 Two of the three sets of discordant MZ twins we reported eventually became concordant. It took 20 years for the second of the twin set identified as 'Dr' in our paper to develop clinical SLE. The twins who remained discordant ('G') died within months of each other, one of dialysis complications related to lupus nephritis, the other of a relatively sudden febrile illness that was not identified even after autopsy, though thought not to represent SLE. The literature cites many similar incidences of long delays in the manifestation of disease for the previously clinically well MZ twin, supporting both genetic and environmental hypotheses.
This tendency to eventually develop clinical SLE for the second of the clinically discordant MZ twins may be related to and heralded by the high prevalence of serologic and immunologic abnormalities in the apparently well siblings. 62, 63 Furthermore, when MZ twin sets do become concordant, their clinical and laboratory presentations are remarkably similar. 8 Twins have continued to provide a unique population for physician scientists to study. Some clinical reports have identified definite environmental factors such as procainamide and hydralazine. 17, 30 Recent studies of lymphocyte populations and function, 49, 55 like older experiments with the mixed lymphocyte reaction 25, 31, 34, 62, 64 have yielded mixed results. Others have studied complement receptors, 36 interleukins, 40 phage displays, 52 hormones 31 and chromosomes. 55 Genetic studies have become much more sophisticated and interesting in recent years. Specific alleles of the histocompatibility complex, including genes that encode for some complement components remain of interest. 65 The study of variations in sex steroid pathway genes may unlock the reasons for female predilection. 66 The identification of genetic variants responsible for various cell surface receptors, cytokines, chemokines, enzymes and opsonins has generated a body of literature indicating the potential for multiple genes alone or in consort with each other to generate the diverse clinical manifestations of SLE. 67 Not that retroviruses have been forgotten. The human genome appears to be rich in endogenous retrovirus-related DNA sequences including elements that encode for reverse transcriptase, and lupus patients produce antibodies that react with retroviral elements. At the Hospital for Special Surgery, the hunt for that retrovirus now enters its fourth decade. 68, 69 The distinction between virology and genetics has become indistinct.
In 2005 one may hypothesize that multiple environmental factors may incite the clinical expression of the disease, depending on the specific genetic tendencies inherited by each individual. What we face today is a complex array of genetic probabilities and environmental possibilities, the interactions between which may be specific for each individual with SLE.
In this context, individual sets of MZ twins, especially those discordant for SLE, remain important subjects for study. And Dr Christian's challenge of a Nobel Prize for the answer to his question, Why does one twin have lupus and the other does not? remainsa reward that I hope will be won by one of today's generation of fellows.
